NO984217D0 - Nitrogenholdige tricykliske forbindelser og medikamenter omfattende disse - Google Patents

Nitrogenholdige tricykliske forbindelser og medikamenter omfattende disse

Info

Publication number
NO984217D0
NO984217D0 NO984217A NO984217A NO984217D0 NO 984217 D0 NO984217 D0 NO 984217D0 NO 984217 A NO984217 A NO 984217A NO 984217 A NO984217 A NO 984217A NO 984217 D0 NO984217 D0 NO 984217D0
Authority
NO
Norway
Prior art keywords
drugs
nitrogen
tricyclic compounds
containing tricyclic
compounds
Prior art date
Application number
NO984217A
Other languages
English (en)
Other versions
NO984217L (no
Inventor
Mitsuaki Miyamoto
Tatsuya Yoshiuchi
Keizo Sato
Makoto Kaino
Masayuki Tanaka
Motohiro Soejiam
Katsuhiro Moriya
Yoshinori Sakuma
Koji Yamada
Kokichi Harada
Yukio Nishizawa
Seiichi Kobayashi
Makoto Okita
Koichi Katayama
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO984217D0 publication Critical patent/NO984217D0/no
Publication of NO984217L publication Critical patent/NO984217L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
    • C07D279/24—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with hydrocarbon radicals, substituted by amino radicals, attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B21/00—Thiazine dyes
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B57/00—Other synthetic dyes of known constitution
    • C09B57/08—Naphthalimide dyes; Phthalimide dyes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO984217A 1996-03-13 1998-09-11 Nitrogenholdige tricykliske forbindelser og medikamenter omfattende disse NO984217L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5562896 1996-03-13
PCT/JP1997/000789 WO1997033871A1 (fr) 1996-03-13 1997-03-13 Composes azotes tricycliques et medicaments les contenant

Publications (2)

Publication Number Publication Date
NO984217D0 true NO984217D0 (no) 1998-09-11
NO984217L NO984217L (no) 1998-11-12

Family

ID=13004054

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984217A NO984217L (no) 1996-03-13 1998-09-11 Nitrogenholdige tricykliske forbindelser og medikamenter omfattende disse

Country Status (8)

Country Link
US (3) US6333322B1 (no)
EP (1) EP0889037A1 (no)
CN (1) CN1216982A (no)
AU (1) AU1939997A (no)
CA (1) CA2248820A1 (no)
HU (1) HUP9902342A3 (no)
NO (1) NO984217L (no)
WO (1) WO1997033871A1 (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6583138B1 (en) 1998-02-27 2003-06-24 Eisai Co., Ltd. Heterocyclic-ring condensed benzothiazine compound
WO2000003734A1 (fr) * 1998-07-17 2000-01-27 Fuji Yakuhin Kogyo Kabushiki Kaisha Agents therapeutiques pour affections allergiques
EP1345917A1 (en) * 2000-12-19 2003-09-24 Ucb, S.A. 2-(2-(4-((2r)-2-methyl-3-(10h-phenothiazin-10-yl)propyl)-1-piperazinyl)-ethoxy)ethanol, process for the preparation thereof, pharmaceutical compositions containing said compound and therapeutic uses thereof
JP4913588B2 (ja) 2003-01-21 2012-04-11 タリオン ファーマシューティカルズ インク． ファルネシルベンゾジアゼピノンの製造方法及び薬剤としての使用
US7655646B2 (en) 2003-01-21 2010-02-02 Thallion Pharmaceuticals, Inc. Dibenzodiazepinone analogues, processes for their production and their use as pharmaceuticals
US7358241B2 (en) 2003-01-21 2008-04-15 Thallion Pharmaceuticals, Inc. Compositions and methods comprising farnesyl dibenzodiazepinones for treating neoplastic cells and conditions
US7186713B2 (en) 2003-01-21 2007-03-06 Ecopia Biosciences, Inc. Farnesyl dibenzodiazepinones and methods of treating cancer using same
WO2005020913A2 (en) * 2003-08-25 2005-03-10 Combinatorx, Incorporated Formulations, conjugates, and combinations of drugs for the treatment of neoplasms
US20070299093A1 (en) * 2005-01-27 2007-12-27 Alma Mater Studiorum-Universitá Di Bologna Organic Compounds Useful for the Treatment of Alzheimer's Disease, Their Use and Method of Preparation
EA200701584A1 (ru) * 2005-01-27 2008-02-28 Альма Матер Студиорум - Университа' Ди Болонья Органические соединения, применяемые для лечения болезни альцгеймера, их применение и способ получения
US7763604B2 (en) 2005-05-16 2010-07-27 Thallion Pharma Ceuticals, Inc. Methods for administration of a farnesyl dibenzodiazepinone
US7829578B1 (en) 2005-12-12 2010-11-09 Oregon Health & Science University Aromatic ketones and uses thereof
ES2667002T3 (es) * 2006-03-29 2018-05-09 Wista Laboratories Ltd. Inhibidores de la agregación de proteínas
PL2013191T6 (pl) 2006-03-29 2019-07-31 Wista Laboratories Ltd. Sole 3,7-diamino-10H-fenotiazynowe i ich zastosowanie
CA2662215A1 (en) * 2006-09-01 2008-03-06 Immune Control, Inc. Novel compositions and methods for treatment of diseases related to activated lymphocytes
WO2008064011A1 (en) 2006-11-13 2008-05-29 The Government Of The U.S. Of America As Represented By The Department Of Veterans Affairs Acridone compounds
AU2009219435A1 (en) * 2008-02-29 2009-09-03 Immune Control, Inc. Novel compositions for treatment of diseases related to activated lymphocytes
WO2010056979A1 (en) * 2008-11-14 2010-05-20 Immune Control, Inc. Phenothiazine derivatives for treatment of asthma
US8598354B2 (en) 2008-12-05 2013-12-03 University Of South Florida Compounds having antiparasitic or anti-infectious activity
AU2011261375B2 (en) 2010-06-04 2016-09-22 Albany Molecular Research, Inc. Glycine transporter-1 inhibitors, methods of making them, and uses thereof
CN103649061B (zh) 2011-02-11 2016-04-20 维斯塔实验室有限公司 吩噻嗪二胺鎓盐和其用途
AU2012292016B2 (en) 2011-08-02 2017-06-01 Helmholtz Zentrum Munchen - Deutsches Forschungszentrum Fur Gesundheit Und Umwelt (Gmbh) Selective inhibition MALT1 protease by phenothiazine derivatives
EP2758403B1 (en) 2011-09-21 2016-04-27 Inception Orion, Inc. Tricyclic compounds useful as neurogenic and neuroprotective agents
WO2014130534A1 (en) 2013-02-19 2014-08-28 Icahn School Of Medicine At Mount Sinai Tricyclic heterocycles as anticancer agents
CN106458936A (zh) 2014-03-11 2017-02-22 西奈山伊坎医学院 作为抗癌药的三环‑2‑氨基环烷醇衍生的磺酰胺
WO2015138496A1 (en) 2014-03-11 2015-09-17 Icahn School Of Medicine At Mount Sinai Constrained tricyclic sulfonamides
JP6966425B2 (ja) 2015-09-09 2021-11-17 アイカーン スクール オブ メディスン アット マウント サイナイIcahn School of Medicine at Mt. Sinai 抗がん剤としての複素環式の限定された三環系スルホンアミド
JP6955485B2 (ja) 2015-09-09 2021-10-27 アイカーン スクール オブ メディスン アット マウント サイナイＩｃａｈｎ Ｓｃｈｏｏｌ ｏｆ Ｍｅｄｉｃｉｎｅ ａｔ Ｍｔ． Ｓｉｎａｉ 抗がん剤としての複素環式の限定された三環系スルホンアミド
CN107068881B (zh) * 2016-04-25 2019-12-03 中节能万润股份有限公司 一种含有吖啶酮类化合物的有机电致发光器件及其应用
US11545691B2 (en) 2017-07-20 2023-01-03 Board Of Trustees Of Michigan State University Redox flow battery
US11414387B2 (en) 2017-11-20 2022-08-16 Stingthera, Inc. Oxoacridinyl acetic acid derivatives and methods of use
MX2020004902A (es) * 2017-11-20 2020-09-09 Silicon Swat Inc Derivados del acido oxoacridinilo acetico y metodos de uso.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3449334A (en) 1967-10-26 1969-06-10 Smithkline Corp 9-(2-(2-piperidinyl)ethyl) and 9-(2-(2-pyrrolidinyl)ethyl)acridanes
GB1258005A (no) 1969-03-27 1971-12-22
JPS502513A (no) 1973-05-07 1975-01-11
IE56998B1 (en) 1982-12-02 1992-03-11 Wellcome Found Phenothiazine derivatives
GB2132194A (en) 1982-12-02 1984-07-04 Wellcome Found Phenothiazines
EP0138481B1 (en) 1983-10-05 1991-06-26 Merck Frosst Canada Inc. Leukotriene biosynthesis inhibitors
US4711889A (en) 1983-11-15 1987-12-08 Hoffman-La Roche Inc. Schistosomicidal acridanone hydrazones
GB8413915D0 (en) 1984-05-31 1984-07-04 Wellcome Found Phenothiazine compounds
DE3531682A1 (de) * 1985-09-05 1987-03-12 Thomae Gmbh Dr K (+)-6-chlor-5,10-dihydro-5-((1-methyl-4- piperidinyl)acetyl)-11h-dibenzo(b,e)(1,4) diazepin-11-on, seine isolierung und verwendung als arzneimittel
IT8721978A0 (it) * 1987-09-21 1987-09-21 Angeli Inst Spa Nuovi derivati ammidinici triciclici.
JPH05163256A (ja) 1991-12-13 1993-06-29 Hokuriku Seiyaku Co Ltd フェノチアジン誘導体

Also Published As

Publication number Publication date
HUP9902342A2 (hu) 2000-08-28
CA2248820A1 (en) 1997-09-18
HUP9902342A3 (en) 2000-09-28
AU1939997A (en) 1997-10-01
US6333322B1 (en) 2001-12-25
EP0889037A1 (en) 1999-01-07
NO984217L (no) 1998-11-12
CN1216982A (zh) 1999-05-19
US6489336B2 (en) 2002-12-03
US20030171367A1 (en) 2003-09-11
US20020103189A1 (en) 2002-08-01
US6703388B2 (en) 2004-03-09
WO1997033871A1 (fr) 1997-09-18

Similar Documents

Publication Publication Date Title
NO984217D0 (no) Nitrogenholdige tricykliske forbindelser og medikamenter omfattende disse
NO307182B1 (no) Farmasoeytiske blandinger og tricykliske forbindelser
NO992838D0 (no) Benzotiofenkarboksamid-derivater og PGD2 antagonister omfattende disse
NO991150D0 (no) Pyrazolopyrimidiner og pyrazolotriaziner
NO972446L (no) Brönnkompleteringsskillefluider og fremgangsmåter
NO985278L (no) Elektromagnetiske-til-akustiske og akustiske-til-elektro-magnetiske forsterkere og fremgangsmÕter for bruk av disse
NO984107L (no) Kappa-agonist-forbindelser og farmas°ytiske preparater derav
NO975894L (no) Foringsr°rpakning
NO20032753D0 (no) Forbindelse og anvendelse derav
NO980605D0 (no) Fremgangsmåter og anordning for komplettering av underjordisk brönn
DE69832657D1 (de) Empfangseinrichtungen und Empfangsverfahren
DE69835254D1 (de) Empfangseinrichtungen und Empfangsverfahren
DK0879814T3 (da) Triaromatiske forbindelser, præparater indeholdende disse og anvendelser
NO943763D0 (no) 4-arylamino-benzopyraner og beslektede forbindelser
DK0729956T3 (da) Benzothi9phenforbindelser, emllemprodukter, præparater og fremgangsmåder
DK0847391T3 (da) Aromatiske forbindelse og farmaceutiske præparater indeholdende disse
NO995324L (no) Baerer for gjenstander og emne for denne
IS5345A (is) Samsett meðferð sem inniheldur amlódipín og statín efnasambönd
NO983576L (no) Br°nnbehandlingsfluider og fremgangsmÕter
NO964541D0 (no) Porphacyanin og CNC-utvidete porphyriner
NO20012542D0 (no) Organofosforforbindelser og anvendelse derav
NO992852D0 (no) Basisstr°mningsenhet
NO992316D0 (no) Benzensulfonamidderivater og legemidler inneholdende disse
NO983556L (no) Formulering og anvendelse
IT236478Y1 (it) Posto cassa trasportabile